Skip to main content
. Author manuscript; available in PMC: 2015 Nov 1.
Published in final edited form as: Biol Psychiatry. 2014 Mar 25;76(9):734–741. doi: 10.1016/j.biopsych.2014.03.019

Table 2.

Demographics and baseline characteristics of the enrolled sample.

Total
sample
Placebo Ghrelin
1 mcg/Kg
Ghrelin
3 mcg/Kg
P
value
Number (n) 45 18 13 14
Females(%) 36 39 31 36 .90
Age (years)
  range 25–62 28–62 25–57 25–58
  M ± SD 44.7 ± 9.1 46.6 ± 9.0 42.8 ± 9.8 43.9 ± 8.6 .49
  median 47 48 43 45
Race/Ethnicity (%)
  Black 31.1 22.2 38.5 35.7
  White 53.3 61.1 46.2 50.0
  Latino 4.4 5.6 7.7 0
  Others 11.1 11.1 7.7 14.3
BMI [M ± SD] 25.8 ± 3.1 26.4 ± 2.5 25.2 ± 3.3 25.7 ± 3.7 .56
Age of onset for alcohol problems
  range 12–52 12–52 14–33 15–36
  M ± SD 21.8 ± 8.1 22.9 ± 10.9 20.3 ± 5.2 21.8 ± 6.0 .68
  median 20 20 19 20
90-day baseline drinks/drinking day 11.8 ± 6.8 11.8 ± 7.9 11.8 ± 6.8 11.8 ± 5.7 1.00
Number of drinks the day before the experimental session 4.5 ± 5.5 4.2 ± 5.3 4.9 ± 5.7 4.5 ± 5.8 .94
Alcohol Dependence Severity (ADS) 11.4 ± 7.0 12.6 ± 8.4 9.0 ± 4.4 12.0 ± 6.8 .35
CIWA-Ar 1.2 ± 1.6 1.7 ± 2.0 1.1 ± 1.4 0.6 ± 0.8 .15
90-day baseline cigarettes/day* 14.8 ± 10.5 16.6 ± 10.8 16.4 ± 14.1 11.1 ± 5.1 .42

M: Median; SD: Standard Deviation; BMI: Body Mass Index; drink = Standard Drinking Unit (SDU); CIWA-Ar: Clinical Institute Withdrawal Assessment of Alcohol Scale, Revised

*

76% of the sample were smokers.

HHS Vulnerability Disclosure